Company Announcements and Press Releases

Novo Nordisk country sites USA Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Croatia Czech Republic Denmark Egypt Estonia Finland France Germany Greece Hungary India Iraq Ireland Israel Italy Japan Korea (Republic) Latvia Lebanon Lithuania Mexico Netherlands New Zealand Norway Pakistan Poland Portugal Romania Russian Federation Serbia Slovak Republic Slovenia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Turkey Ukraine United Kingdom Other Novo Nordisk sites Changing diabetes NovoMedLink DAWN study Hagedorn Research Institute Diabetes4Patients Diabetes Barometer Changing diabetes bus Media prize World diabetes day School challenge Improve Control HRT for HCPs HRT for women HRT congresses & symposia

• News
• Facts about Novo Nordisk
• R&D pipeline
• Download centre
• Diabetes dictionary
• Broadcast room
• Photos
• Subscription
• Victoza® (liraglutide) press room
• Contact

• 
• Print

News

In the News part you can find Company Announcements and press releases as downloadable PDF files in English and Danish.

Company Announcements

Novo Nordisk A/S - Share repurchase programme (26 July 2010)

Novo Nordisk A/S - Share repurchase programme (19 July 2010)

Novo Nordisk A/S - Share repurchase programme (12 July 2010)

Press Releases

New data demonstrate Victoza® (liraglutide) provided superior and sustained blood sugar control and weight reduction compared to Januvia® (sitagliptin) at 52 weeks (26 June 2010)

Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week (26 June 2010)

Victoza® to be launched in Japan in June (2 June 2010)

Online News

Novo Nordisk commits to women’s empowerment (25 June 2010)

Steno opens Health Promotion Center (11 June 2010)

Health Canada approves Victoza (26 May 2010)